Viewbix Inc.

Quantum X Labs Inc. (formerly Viewbix Inc.) reported a net income attributable to shareholders of $2.485 million for Q2 2026, a significant improvement from a $11.658 million loss in Q2 2025. This turnaround was primarily driven by a $3.831 million gain from the deconsolidation of CliniQuantum. However, revenues declined by 20.8% to $293 thousand, and the operating loss widened to $1.395 million. The company also issued a going concern warning due to declining revenues and increased operating losses, despite strategic shifts into quantum technology and recent fundraising efforts.

Quantum X Labs Inc. announced the launch of its 50+ qubit neutral-atom quantum computing platform, featuring proprietary atom cooling technology and dynamically reconfigurable optical tweezer arrays. The company aims to scale to thousands of qubits by the end of H1 2027, leveraging a logical qubit pathway strategy that integrates its pending patented AI-based error correction system. This platform is designed to support advanced applications across various high-impact domains.

Quantum X Labs Inc. announced the appointment of Mr. Yakov Baranes as co-Chief Executive Officer, effective May 18, 2026. He will serve alongside current CEO Mr. Amihay Hadad. Mr. Baranes, a business strategy expert, previously led Quantum Israel, a subsidiary acquired by the company, and will receive a monthly base salary of NIS 36,000 plus an additional NIS 24,000 for services to Quantum Israel. He also received shares and warrants related to the acquisition of Quantum Israel, with potential for more upon milestone achievement.

Quantum X Labs Inc. (formerly Viewbix Inc.) completed the acquisition of Quantum X Labs Ltd. on March 4, 2026, marking a strategic shift to quantum technology, digital advertising, and AI solutions, and subsequently rebranded. For Q1 2026, the company reported a net loss of $605k, a significant improvement from $3,844k in Q1 2025, but revenues declined to $353k from $529k. Despite recent fundraising efforts, management expressed substantial doubt about the company's ability to continue as a going concern due to declining revenues and increased operating losses.

Quantum X Labs Inc. (formerly Viewbix Inc.) filed an 8-K to provide financial disclosures related to its acquisition of Quantum X Labs Ltd. (Quantum Israel), which closed on March 4, 2026. The filing includes audited financial statements for Quantum Israel for the year ended December 31, 2025, and unaudited pro forma combined financial information for the combined entity. Quantum Israel reported a net loss of $325 thousand and has a going concern uncertainty, while the pro forma combined entity showed a net loss of $21,140 thousand for the year ended December 31, 2025.

Viewbix Inc. announced a comprehensive corporate rebranding to Quantum X Labs Inc., effective April 30, 2026, with a new ticker symbol "QXL". This move signifies the company's evolution towards developing and owning quantum computing technology, quantum error correction, simulations, and sensing technologies. The rebranding builds on the acquisition of Quantum X Labs Ltd. in March 2026, which holds a robust IP portfolio and several quantum technology subsidiaries, while the company will also continue its legacy digital advertising activities.